TONIX PHARMACEUTICALS HOLDING CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.25 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 219.80K shares, a 54.18% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.03M shares, a 53.30% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 54.60K shares.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 7.80K shares, a 84.40% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.21M shares, a 34931.52% increase from fiscal 2024.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.46K shares, a 825.40% increase from fiscal 2023.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 374.00 shares, a 99.87% decline from fiscal 2022.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 298.66K shares, a 38.63% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 219.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 1.25M shares 10-Q · filed 2026-08-10 | 1.30M shares derived: sum of 3 quarters · filed 2026-08-10 | 1.31M shares derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | 1.03M shares 10-Q · filed 2026-05-11 | 1.08M shares derived: sum of 2 quarters · filed 2026-05-11 | 1.09M shares derived: sum of 3 quarters · filed 2026-05-11 | 1.57M shares derived: sum of 4 quarters · filed 2026-05-11 | |
| 2025-12-31 | 54.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 62.40K shares derived: sum of 2 quarters · filed 2026-03-12 | 542.15K shares derived: sum of 3 quarters · filed 2026-03-12 | 1.21M shares 10-K · filed 2026-03-12 | |
| 2025-09-30 | 7.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 487.55K shares derived: sum of 2 quarters · filed 2025-11-10 | 1.16M shares 10-Q · filed 2025-11-10 | 822.37K shares derived: sum of 4 quarters · filed 2026-03-12 | |
| 2025-06-30 | 479.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 1.15M shares 10-Q · filed 2025-08-11 | 814.57K shares derived: sum of 3 quarters · filed 2026-03-12 | 864.57K shares derived: sum of 4 quarters · filed 2026-03-12 | |
| 2025-03-31 | 670.29K shares 10-Q · filed 2025-05-12 | 334.82K shares derived: sum of 2 quarters · filed 2026-03-12 | 384.82K shares derived: sum of 3 quarters · filed 2026-03-12 | -7.80M shares derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-12-31 | -335.47K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -285.47K shares derived: sum of 2 quarters · filed 2026-03-12 | -8.47M shares derived: sum of 3 quarters · filed 2026-03-12 | 3.46K shares 10-K · filed 2026-03-12 | |
| 2024-09-30 | 50.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -8.14M shares derived: sum of 2 quarters · filed 2024-11-12 | 338.93K shares 10-Q · filed 2024-11-12 | -679.82K shares derived: sum of 4 quarters · filed 2025-03-18 | |
| 2024-06-30 | -8.19M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | 288.93K shares 10-Q · filed 2024-08-16 | -729.82K shares derived: sum of 3 quarters · filed 2025-03-18 | -722.32K shares derived: sum of 4 quarters · filed 2025-03-18 | |
| 2024-03-31 | 8.48M shares 10-Q · filed 2024-05-13 | 7.46M shares derived: sum of 2 quarters · filed 2025-03-18 | 7.47M shares derived: sum of 3 quarters · filed 2025-03-18 | 2.67M shares derived: sum of 4 quarters · filed 2025-03-18 | |
| 2023-12-31 | -1.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -1.01M shares derived: sum of 2 quarters · filed 2025-03-18 | -5.80M shares derived: sum of 3 quarters · filed 2025-03-18 | 374.00 shares 10-K · filed 2025-03-18 | 1.02M shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 7.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -4.79M shares derived: sum of 2 quarters · filed 2023-11-09 | 1.02M shares 10-Q · filed 2023-11-09 | -377.82K shares derived: sum of 4 quarters · filed 2024-04-01 | |
| 2023-06-30 | -4.79M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 1.01M shares 10-Q · filed 2023-08-10 | -385.32K shares derived: sum of 3 quarters · filed 2024-04-01 | -385.32K shares derived: sum of 4 quarters · filed 2024-04-01 | |
| 2023-03-31 | 5.80M shares 10-Q · filed 2023-05-08 | 4.41M shares derived: sum of 2 quarters · filed 2024-04-01 | 4.41M shares derived: sum of 3 quarters · filed 2024-04-01 | -34.56M shares derived: sum of 4 quarters · filed 2024-04-01 | |
| 2022-12-31 | -1.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -1.40M shares derived: sum of 2 quarters · filed 2024-04-01 | -40.36M shares derived: sum of 3 quarters · filed 2024-04-01 | 298.66K shares 10-K · filed 2024-04-01 | 1.70M shares 10-K · filed 2023-03-13 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -38.97M shares derived: sum of 2 quarters · filed 2022-11-07 | 1.70M shares 10-Q · filed 2022-11-07 | -13.39M shares derived: sum of 4 quarters · filed 2023-03-13 | |
| 2022-06-30 | -38.97M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 1.70M shares 10-Q · filed 2022-08-08 | -13.39M shares derived: sum of 3 quarters · filed 2023-03-13 | -12.58M shares derived: sum of 4 quarters · filed 2023-03-13 | |
| 2022-03-31 | 40.66M shares 10-Q · filed 2022-05-09 | 25.58M shares derived: sum of 2 quarters · filed 2023-03-13 | 26.38M shares derived: sum of 3 quarters · filed 2023-03-13 | 28.37M shares derived: sum of 4 quarters · filed 2023-03-13 | |
| 2021-12-31 | -15.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -14.28M shares derived: sum of 2 quarters · filed 2023-03-13 | -12.29M shares derived: sum of 3 quarters · filed 2023-03-13 | 486.64K shares 10-K · filed 2023-03-13 | 15.57M shares 10-K · filed 2022-03-14 |
| 2021-09-30 | 808.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 2.80M shares derived: sum of 2 quarters · filed 2021-11-08 | 15.57M shares 10-Q · filed 2021-11-08 | 15.57M shares derived: sum of 4 quarters · filed 2022-03-14 | |
| 2021-06-30 | 1.99M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 14.76M shares 10-Q · filed 2021-08-09 | 14.76M shares derived: sum of 3 quarters · filed 2022-03-14 | 14.76M shares derived: sum of 4 quarters · filed 2022-03-14 | |
| 2021-03-31 | 12.77M shares 10-Q · filed 2021-05-10 | 12.77M shares derived: sum of 2 quarters · filed 2022-03-14 | 12.77M shares derived: sum of 3 quarters · filed 2022-03-14 | 22.32M shares derived: sum of 4 quarters · filed 2022-03-14 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-14 | 9.54M shares derived: sum of 3 quarters · filed 2022-03-14 | 10.10M shares 10-K · filed 2022-03-14 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 9.54M shares derived: sum of 2 quarters · filed 2020-11-09 | 10.10M shares 10-Q · filed 2020-11-09 | 10.10M shares derived: sum of 4 quarters · filed 2021-03-15 | |
| 2020-06-30 | 9.54M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 10.10M shares 10-Q · filed 2020-08-10 | 10.10M shares derived: sum of 3 quarters · filed 2021-03-15 | 9.24M shares derived: sum of 4 quarters · filed 2021-03-15 | |
| 2020-03-31 | 556.50K shares 10-Q · filed 2020-05-12 | 556.50K shares derived: sum of 2 quarters · filed 2021-03-15 | -303.08K shares derived: sum of 3 quarters · filed 2021-03-15 | 538.62K shares derived: sum of 4 quarters · filed 2021-03-15 | |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -859.58K shares derived: sum of 2 quarters · filed 2021-03-15 | -17.88K shares derived: sum of 3 quarters · filed 2021-03-15 | 95.52K shares 10-K · filed 2021-03-15 | |
| 2019-09-30 | -859.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -17.88K shares derived: sum of 2 quarters · filed 2019-11-08 | 95.52K shares 10-Q · filed 2019-11-08 | -913.91K shares derived: sum of 4 quarters · filed 2020-03-24 | |
| 2019-06-30 | 841.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | 955.10K shares 10-Q · filed 2019-08-12 | -54.33K shares derived: sum of 3 quarters · filed 2020-03-24 | -39.33K shares derived: sum of 4 quarters · filed 2020-03-24 | |
| 2019-03-31 | 113.40K shares 10-Q · filed 2019-05-13 | -896.03K shares derived: sum of 2 quarters · filed 2020-03-24 | -881.03K shares derived: sum of 3 quarters · filed 2020-03-24 | -711.03K shares derived: sum of 4 quarters · filed 2020-03-24 | |
| 2018-12-31 | -1.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | -994.43K shares derived: sum of 2 quarters · filed 2020-03-24 | -824.43K shares derived: sum of 3 quarters · filed 2020-03-24 | 10.21K shares 10-K · filed 2020-03-24 | 101.97K shares 10-K · filed 2019-03-18 |
| 2018-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 185.00K shares derived: sum of 2 quarters · filed 2018-11-09 | 1.02M shares 10-Q · filed 2018-11-09 | 785.63K shares derived: sum of 4 quarters · filed 2019-03-18 | |
| 2018-06-30 | 170.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | 1.00M shares 10-Q · filed 2018-08-13 | 770.63K shares derived: sum of 3 quarters · filed 2019-03-18 | 790.63K shares derived: sum of 4 quarters · filed 2019-03-18 | |
| 2018-03-31 | 834.63K shares 10-Q · filed 2018-05-11 | 600.63K shares derived: sum of 2 quarters · filed 2019-03-18 | 620.63K shares derived: sum of 3 quarters · filed 2019-03-18 | 770.63K shares derived: sum of 4 quarters · filed 2019-03-18 | |
| 2017-12-31 | -234.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -214.00K shares derived: sum of 2 quarters · filed 2019-03-18 | -64.00K shares derived: sum of 3 quarters · filed 2019-03-18 | 26.00K shares 10-K · filed 2019-03-18 | 260.00K shares 10-K · filed 2018-03-09 |
| 2017-09-30 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | 170.00K shares derived: sum of 2 quarters · filed 2017-11-06 | 260.00K shares 10-Q · filed 2017-11-06 | -368.20K shares derived: sum of 4 quarters · filed 2018-03-09 | |
| 2017-06-30 | 150.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | 240.00K shares 10-Q · filed 2017-08-11 | -388.20K shares derived: sum of 3 quarters · filed 2018-03-09 | -388.20K shares derived: sum of 4 quarters · filed 2018-03-09 | |
| 2017-03-31 | 90.00K shares 10-Q · filed 2017-05-12 | -538.20K shares derived: sum of 2 quarters · filed 2018-03-09 | -538.20K shares derived: sum of 3 quarters · filed 2018-03-09 | 148.01K shares derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-12-31 | -628.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -628.20K shares derived: sum of 2 quarters · filed 2018-03-09 | 58.01K shares derived: sum of 3 quarters · filed 2018-03-09 | 69.80K shares 10-K · filed 2018-03-09 | |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 686.21K shares derived: sum of 2 quarters · filed 2016-11-10 | 698.00K shares 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | 686.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | 698.00K shares 10-Q · filed 2016-08-05 | |||
| 2016-03-31 | 11.79K shares 10-Q · filed 2016-05-06 | ||||
| 2015-12-31 | 51.32K shares 10-K · filed 2017-04-13 | 651.36K shares 10-K · filed 2016-03-03 | |||
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 7.14K shares 10-Q · filed 2015-08-07 | |||
| 2015-03-31 | 7.14K shares 10-Q · filed 2015-05-08 | ||||
| 2014-12-31 | 850.30K shares 10-K · filed 2015-02-27 | ||||
| 2013-12-31 | 226.50K shares 10-K · filed 2015-02-27 | ||||
| 2012-12-31 | 175.00K shares 10-K · filed 2014-03-28 | 3.50M shares 10-K · filed 2013-03-11 | |||
| 2012-06-30 | 3.50M shares 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |